Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;92:586-588
doi: 10.1161/01.RES.0000066881.04116.45
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeon, B. H.
Right arrow Articles by Irani, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeon, B. H.
Right arrow Articles by Irani, K.
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
(Circulation Research. 2003;92:586.)
© 2003 American Heart Association, Inc.


Editorials

Tie-ing the Antiinflammatory Effect of Angiopoietin-1 to Inhibition of NF-{kappa}B

Byeong Hwa Jeon, Firdous Khanday, Shailesh Deshpande, Azeb Haile, Michitaka Ozaki, Kaikobad Irani

From the Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Kaikobad Irani, The Johns Hopkins University School of Medicine, Ross 1023, 720 Rutland Ave, Baltimore, MD 21205. E-mail kirani@jhmi.edu


Key Words: angiopoietin-1 • Tie2 • nuclear factor-{kappa}B • endothelial cells • ABIN-2


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Activation of the vascular endothelium occurs in many clinical scenarios such as inflammatory or infectious conditions (sepsis), reperfusion injury, and transplant graft rejection.1–5 Under such circumstances, endothelial activation is primarily induced by cytokines such as tumor necrosis factor (TNF) and interleukin-1ß (IL-1ß) and vascular permeability factors such as vascular endothelial growth factor (VEGF) that upregulate a number of genes including prothrombotic factors, chemokines, and cell adhesion molecules, many of which are dependent on the action of the pleiotropic transcription factor nuclear factor-{kappa}B (NF-{kappa}B).2,6–11 Activated endothelium is compromised in its structural and functional integrity, leading to transmigration of leukocytes into the vessel wall, plasma leakage, and thrombosis.

Angiopoeitin-1 (Ang1) is a vasculogenic factor that induces endothelial cell sprouting, migration, and network formation,12–15 coordinated processes that are crucial in the development of new blood vessels. Angiopoietins signal via the Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domains) family of receptor tyrosine kinases, of which Tie2 is endothelial-cell specific. In addition to its important role in vasculogenesis, Ang1, through Tie2, suppresses activation of endothelial cells as evidenced by its inhibition of vascular cell adhesion molecules and procoagulant tissue factor expression.16,17 These effects confer on Ang1 potent antiinflammatory properties.18–20 Although Ang1 affects the expression of many NF-{kappa}B–responsive genes, a functional and mechanistic link between Ang1 and NF-{kappa}B signaling has not been previously shown.

The report by Hughes et al21 in this issue of Circulation Research provides the first demonstration that the mitigating effect . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. K. Biswas, A. Sica, and C. E. Lewis
Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms
J. Immunol., February 15, 2008; 180(4): 2011 - 2017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Dewachter, S. Adnot, E. Fadel, M. Humbert, B. Maitre, A.-M. Barlier-Mur, G. Simonneau, M. Hamon, R. Naeije, and S. Eddahibi
Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 1025 - 1033.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Pfaff, U. Fiedler, and H. G. Augustin
Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking
J. Leukoc. Biol., October 1, 2006; 80(4): 719 - 726.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Scharpfenecker, U. Fiedler, Y. Reiss, and H. G. Augustin
The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism
J. Cell Sci., February 15, 2005; 118(4): 771 - 780.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
U. Fiedler, M. Scharpfenecker, S. Koidl, A. Hegen, V. Grunow, J. M. Schmidt, W. Kriz, G. Thurston, and H. G. Augustin
The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies
Blood, June 1, 2004; 103(11): 4150 - 4156.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Tadros, D. P. Hughes, B. J. Dunmore, and N. P. J. Brindle
ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1
Blood, December 15, 2003; 102(13): 4407 - 4409.
[Abstract] [Full Text] [PDF]